The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: A population-based study

Archives of Iranian Medicine

Volumn 12, Issue 3, 2009, Pages 225-231

  Merat, Shahin ^a   Rezvan, Houri ^b   Nouraie, Mehdi ^a,c   Jamali, Arsia ^a   Assari, Shervin ^d   Abolghasemi, Hassan ^b   Radmard, Amir Reza ^a   Zaer Rezaii, Hanieh ^a   Zeid Abadi Nejhad, Mahmood ^e   Hosseini, Mohammad Reza ^e   Amini Kafiabad, Sedigheh ^b   Maghsudlu, Mahtab ^b   Pourshams, Akram ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c HOWARD UNIVERSITY   (United States)

^d Medicine and Health Promotion Institute   (Iran)

^e NAJA Khatam ol Anbia Hospital   (Iran)

Author keywords

Hepatitis B virus; Iran; Prevalence

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HIGH SCHOOL STUDENT; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RURAL AREA; SEX DIFFERENCE; URBAN AREA; VACCINATION; ADOLESCENT; AGE DISTRIBUTION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEALTH SURVEY; IMMUNOLOGY; MIDDLE AGED; SEX RATIO; VIROLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SEX DISTRIBUTION; YOUNG ADULT;

EID: 69149096126     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
2. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South-East Asia. Gut. 1996; 38 (suppl 2): S18-S23.
3. Shamszad M, Farzadgan H. Hepatitis B- related cirrhosis and hepatocellular carcinoma in Iran. J Irn Med Council. 1982; 8: 238.
4. Bagheri- Lankarani K, Saberi-Firoozi M, Nabipoor I, Fattahi F, Sarafraz-Yazdi M, Malekzadeh R. Reassessment of the role of hepatitis B and C viruses in post necrotic cirrhosis and chronic hepatitis in southern Iran. Irn J Med Sci. 1999; 24: 117-121.
5. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Irn Med. 2000; 3: 192-201.
6. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population: a viral marker study. Ann Acad Med Singapore. 1980; 9: 144-148.
7. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high-risk groups in Iran. Vox Sang. 1979; 37: 182-186.
8. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Nowroozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2: 290-298.
9. Jahani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine 2003; 21: 1948-1951.
10. Aali BS. The prevalence of HBsAg among pregnant women referred to Kerman maternity hospital in 1997. J Kerman Univ Med Sci. 1997; 6: 89-96.
11. Mohammad-Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of HBsAg, HCV Ab, and HIV Ab in drug abuser prisoners in Central Hamadan Jail. Res Med Sci. 2002; 7: 311-313.
12. Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus, and hepatitis C virus infections in drug addicts among Zanjan prisoners. Arch Iranian Med. 2003; 6: 1-4.
13. Talaie H, Shadnia SH, Okazi A, Pajouhmand A, Hasanian H, Arianpoor H. The prevalence of hepatitis B, hepatitis C, and HIV infections in non-IV drug opioid poisoned patients in Tehran, Iran. Pak J Biol Sci. 2007; 10: 220-224.
14. Farajzadeh S, Shakibi MR, Moghaddam SD, Rahnama Z. Behcet disease: clinical spectrum and association with hepatitis B and C viruses. East Mediterr Health J. 2005; 11: 68-72.
15. Ghanaat J, Sadeghian A, Ghazvini K, Nassiri MR. Prevalence and risk factors for hepatitis B virus infection among STD patients in northeast region of Iran. Med Sci Monit. 2003; 9: CR91-CR94.
16. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007; 17: 425-433.
17. Zali MR, Mohammad K, Noorbala AA, Noorinayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005; 11: 62-67.
18. Amini-Kafiabad S, Houri R, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998 to 2007. Transfus Med.[in press]
19. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol. 2005; 20: 229-233.
20. Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan Province of Iran. Saudi Med J. 2003; 24: 549-551.
21. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J. 2000; 6: 1114-1116.
22. Alizadeh AH, Ranjbar M, Ansari S, Mir-Arab A, Alavian SM, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J. 2006; 12: 528-537.
23. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta, and human immunodeficiency virus infections in Hamadan Province, Iran: a population-based study. J Trop Med Hyg. 1993; 96: 277-287.
24. Pourshams A, Nasiri J, Mohammadkhani A, Nasrollahzadeh D. Hepatitis B in Gonbad-e-Kavoos: prevalence, risk factors, and intrafamilial spreading [in Persian]. Govaresh. 2004; 9: 222-225.
25. Ganji A, Safavi M, Nouraie SM, Nasseri-Moghadam S, Merat S, Vahedi H, et al. Digestive and liver diseases statistics in several referral centers in Tehran, 2000-2004 [in Persian]. Govaresh. 2006; 11: 33-38.
26. Malekzadeh R, Dehpour AR. Report from Iran. Liver Int. 2008; 28: 1136-1139.
27. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, et al. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat. 2008; 15: 753-760.
28. Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, et al. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study. J Hepatol. 2008; 49: 884-891.
29. Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, et al. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev. 2006; 30: 14-19.
30. Bonino F, Marcellin P, Lau GK, Hadziyannis S, Jin R, Piratvisuth T, et al. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B. Gut. 2007; 56: 699-705.